PDAC-005

胰腺导管腺癌(PDAC)

亚洲 58岁 女 中国 Total Cost: 293

Patient Condition

患者于56岁因上腹痛就诊,CT显示胰腺体部占位,活检确诊为胰腺导管腺癌III期(T4N1M0),不可切除。一线吉西他滨+白蛋白紫杉醇化疗6周期后进展,二线FOLFIRINOX方案3周期后肝转移进展。来诊时CA19-9升高至750 U/mL,肝多发转移灶,ECOG评分2分。

Treatment Timeline

PhaseDetailsDate
???????????
???????+???
?????????

Treatment Outcome

before??????III???????????????????ECOG 2??CA19-9 750 U/mL?KRAS G12D??
afterR0?????????24??????????????ECOG 0??CA19-9??
highlight??????R0????+24??????????????????????????????????